Progency 10 mg (Tablet)

Unit Price: ৳ 30.00 (2 x 10: ৳ 600.00)

Strip Price: ৳ 300.00

Medicine Details

Category	Details
Generic	Dydrogesterone
Company	Healthcare pharmaceuticals ltd

Treatment of threatened miscarriage
Treatment of habitual miscarriage
Treatment of dysmenorrhoea
Treatment of endometriosis
Treatment of secondary amenorrhoea
Treatment of irregular cycles
Treatment of dysfunctional uterine bleeding
Treatment of infertility due to luteal insufficiency
Luteal support as part of an Assisted Reproductive Technology (ART)
To counteract the effects of unopposed oestrogen on the endometrium in hormone replacement therapy for women with disorders due to natural or surgical induced menopause with an intact uterus

Orally-active progestogen
Produces complete secretory endometrium in an oestrogen-primed uterus
Protection against increased risk for endometrium hyperplasia and carcinogenesis induced by oestrogens
No oestrogenic, androgenic, thermogenic, anabolic, or corticoid activity

Threatened miscarriage: 40 mg (four tablets) at once, then 10 mg (one tablet) every eight hours until symptoms remit
Habitual miscarriage: 10 mg (one tablet) twice daily until the twentieth week of pregnancy
Dysmenorrhoea: 10 mg (one tablet) twice daily from day 5 to day 25 of the menstrual cycle
Endometriosis: 10 mg (one tablet) two or three times daily from day 5 to day 25 of the cycle or continuously
Dysfunctional bleeding (to arrest bleeding): 10 mg (one tablet) twice daily for five to seven days
Dysfunctional bleeding (to prevent bleeding): 10 mg (one tablet) twice daily from day 11 to day 25 of the cycle
Amenorrhoea: An oestrogen once daily from day 1 to day 25 of the cycle, together with 10 mg Presentation twice daily from day 11 to day 25 of the cycle
Irregular cycles: 10 mg (one tablet) twice daily from day 11 to day 25 of the cycle
Infertility due to luteal insufficiency: 10 mg (one tablet) daily from day 14 to day 25 of the cycle. The treatment should be continued for at least 6 consecutive cycles. It is advisable to continue this treatment during the first month of any pregnancy using the doses stated with respect to habitual miscarriage
Luteal support as part of an Assisted Reproductive Technology (ART) treatment: 10 mg three times daily (three tablets daily) starting at the day of oocyte retrieval and continuing for 10 weeks if pregnancy is confirmed

In combination with continuous oestrogentherapy, take one tablet daily for 14 consecutive days of a 28 day cycle
In combination with cyclical oestrogen therapy take one tablet daily during the last 12 to 14 days of oestrogen therapy
If endometrial biopsies or ultrasound reveal inadequate Presentationational response, 20 mg Dydrogesterone should be prescribed

Before initiating treatment for abnormal bleeding, clarify the etiology
Breakthrough bleeding and spotting may occur during the first months of treatment
Investigate the reason for breakthrough bleeding or spotting
Monitor for severe headache, migraine, symptoms indicating cerebral ischemia, marked increase in blood pressure, occurrence of venous thromboembolism (VTE)
In cases of habitual or threatened abortion, ascertain the viability of the foetus
Carefully monitor patients with a history of depression

Progency was well tolerated after oral dosing (maximum daily dose is 360 mg)
No reports of ill effects from overdose
If a large overdose is discovered within two or three hours, consider gastric lavage